$2.92
-0.03 (-0.90%)
Open$2.87
Previous Close$2.95
Day High$3.02
Day Low$2.76
52W High$24.60
52W Low$1.83
Volume—
Avg Volume6.3K
Market Cap15.86M
P/E Ratio—
EPS$-6.38
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,289.4% upside
Current
$2.92
$2.92
Target
$40.57
$40.57
$36.99
$40.57 avg
$64.99
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 5.39M | 5.45M | 4.30M |
| Net Income | -1,299,864 | -1,279,500 | -760,803 |
| Profit Margin | -24.1% | -23.5% | -17.7% |
| EBITDA | -1,608,718 | -1,854,994 | -1,475,925 |
| Free Cash Flow | -1,268,218 | -1,023,573 | -724,682 |
| Rev Growth | -8.0% | -5.0% | +17.9% |
| Debt/Equity | 0.74 | 0.71 | 0.67 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |